Search Results - Nolan, Christopher
Christopher Nolan
Nolan developed an interest in filmmaking from a young age. After studying English literature at University College London, he made several short films before his feature film debut with ''Following'' (1998). Nolan gained international recognition with his second film, ''Memento'' (2000), and transitioned into studio filmmaking with ''Insomnia'' (2002). He became a high-profile director with ''The Dark Knight'' trilogy (2005–2012) and found further success with ''The Prestige'' (2006), ''Inception'' (2010), ''Interstellar'' (2014) and ''Dunkirk'' (2017). After the release of ''Tenet'' (2020), Nolan parted ways with longtime distributor Warner Bros. Pictures and signed with Universal Pictures for ''Oppenheimer'' (2023), which won him Academy Awards for Best Director and Best Picture.
Nolan's work regularly features in the listings of best films of their respective decades. Infused with a metaphysical outlook, his films thematise epistemology, existentialism, ethics, the construction of time and the malleable nature of memory and personal identity. They feature mathematically inspired images and concepts, unconventional narrative structures, practical special effects, experimental soundscapes, large-format film photography and materialistic perspectives. His enthusiasm for the use and preservation of traditional film stock in cinema production as opposed to digital cameras has also garnered significant attention. He has co-written several of his films with his brother, Jonathan, and runs the production company Syncopy Inc. with his wife, Emma Thomas. Provided by Wikipedia
- Showing 1 - 20 results of 20
-
1
-
2
-
3
-
4
The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours by El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad, Green, Andrew R.
Published 2018Get full text
-
5
-
6
Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein by Alshareeda, Alaa, Negm, Ola H., Aleskandarany, Mohammed A., Green, Andrew R., Nolan, Christopher, Tighe, Patrick J., Madhusudan, Srinivasan, Ellis, Ian O., Rakha, Emad
Published 2016Get full text
-
7
-
8
Thioredoxin interacting protein (TXNIP) is an independent risk stratifier for breast ductal carcinoma in situ by Miligy, Islam, Gorringe, Kylie L., Toss, Michael S., Al-Kawaz, Abdubaqi, Simpson, Peter, Diez-Rogriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Green, Andrew R., Rakha, Emad
Published 2018Get full text
-
9
-
10
Heterogeneity of Tumour Infiltrating Lymphocytes (TILs) in breast cancer and its prognostic significance by Althobiti, Maryam, Aleskandarany, Mohammed A., Joseph, Chitra, Toss, Michael, Mongan, Nigel, Diez-Rodriguez, Maria, Nolan, Christopher C., Ashankyty, Ibraheem, Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Published 2018Get full text
-
11
Heterogeneity of tumour infiltrating lymphocytes (TILs) in breast cancer and its prognostic significance by Althobiti, Maryam, Aleskandarany, Mohammed A., Joseph, Chitra, Toss, Michael S., Mongan, Nigel P., Diez-Rodriguez, Maria, Nolan, Christopher C., Ashankyty, I., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Published 2018Get full text
-
12
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections by Muftah, Abir A., Aleskandarany, Mohammed A., Al-kaabi, Methaq M., Sonbul, Sultan N., Diez-Rodriguez, Maria, Nolan, Christopher C., Caldas, Carlos, Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Published 2017Get full text
-
13
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer by Green, Andrew R., Soria, Daniele, Powe, Desmond G., Nolan, Christopher C., Aleskandarany, Mohammed A., Szász, M.A., Tőkés, A.M., Ball, G.R., Garibaldi, Jonathan M., Rakha, Emad, Kulka, J., Ellis, Ian O.
Published 2016Get full text
-
14
Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion by Sonbul, Sultan N., Aleskandarany, Mohammed A., Kurozumi, Sasagu, Joseph, Chitra, Toss, Michael S., Diez-Rodriguez, Maria, Nolan, Christopher C., Mukherjee, Abhik, Martin, Stewart, Caldas, Carlos, Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Published 2018Get full text
-
15
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes by Joseph, Chitra, Macnamara, Olivia, Craze, Madeleine, Russell, Roslin, Provenzano, Elena, Nolan, Christopher C., Diez-Rodriguez, Maria, Sonbul, Sultan N., Aleskandarany, Mohammed A., Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Mukherjee, Abhik
Published 2018Get full text
-
16
Clinical utility of reverse phase protein array for molecular classification of breast cancer by Negm, Ola H., Muftah, Abir A., Aleskandarany, Mohammed A., Hamed, Mohamed R., Ahmad, Dena A.J., Nolan, Christopher C., Diez-Rodriguez, Maria, Tighe, Patrick J., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Published 2016Get full text
-
17
MYC regulation of Glutamine-Proline regulatory axis is key in Luminal B breast cancer by Craze, Madeleine L., Cheung, Hayley, Jewa, Natasha, Coimbra, Nuno D.M., Soria, Daniele, El-Ansari, Rokaya, Aleskandarany, Mohammed A., Cheng, Kiu Wai, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad, Green, Andrew R.
Published 2017Get full text
-
18
Nottingham Prognostic Index Plus: validation of a clinical decision making tool in breast cancer in an independent series by Green, Andrew R., Soria, Daniele, Stephen, Jacquelin, Powe, Desmond G., Nolan, Christopher C., Kunkler, Ian, Thomas, Jeremy, Kerr, Gillian R., Jack, Wilma, Cameron, David, Piper, Tammy, Ball, Graham R., Garibaldi, Jonathan M., Rakha, Emad, Bartlett, John M.S., Ellis, Ian O.
Published 2016Get full text
-
19
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis by Kurozumi, Sasagu, Joseph, Chitra, Sonbul, Sultan, Gorringe, Kylie L., Pigera, Marian, Aleskandarany, Mohammed A., Diez-Rodriguez, Maria, Nolan, Christopher C., Fujii, Takaaki, Shirabe, Ken, Kuwano, Hiroyuki, Storr, Sarah, Martin, Stewart G., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Published 2018Get full text
-
20
Clinicopathological and prognostic significance of Ras Association and Pleckstrin Homology domains 1 (RAPH1) in breast cancer by Kurozumi, Sasagu, Joseph, Chitra, Sonbul, Sultan, Aleskandarany, Mohammed A., Pigera, Marian, Alsaleem, Mansour, Alsaeed, Sami, Kariri, Yousif, Nolan, Christopher C., Diez-Rodriguez, Maria, Johnston, Simon, Mongan, Nigel P., Fujii, Takaaki, Shirabe, Ken, Martin, Stewart G., Ellis, Ian O., Green, Andrew R., Rakha, Emad A.
Published 2018Get full text